Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection
- 1 July 2005
- Vol. 128 (1) , 116-123
- https://doi.org/10.1378/chest.128.1.116
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Use of Isoniazid for Latent Tuberculosis Infection in a Public Health ClinicAmerican Journal of Respiratory and Critical Care Medicine, 2003
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Pyrazinamide and Rifampin vs Isoniazid for the Treatment of Latent TuberculosisChest, 2003
- Twelve Months of Isoniazid Compared with Four Months of Isoniazid and Rifampin for Persons with Radiographic Evidence of Previous TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized TrialJAMA, 2000
- Isoniazid-associated Hepatitis Deaths: A Review of Available InformationAmerican Review of Respiratory Disease, 1992
- Twenty Isoniazid-associated Deaths in One StateAmerican Review of Respiratory Disease, 1989
- Isoniazid ChemoprophylaxisArchives of internal medicine (1960), 1977
- Serum Transaminase Elevations and Other Hepatic Abnormalities in Patients Receiving IsoniazidAnnals of Internal Medicine, 1969
- Fatal Hepatic Necrosis Secondary to Isoniazid TherapyPublished by American Medical Association (AMA) ,1961